The potential of circulating tumor DNA (ctDNA) to reshape the design of clinical trials testing adjuvant therapy in patients with early stage cancers.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jeanne Tie, Yuxuan Wang, Cristian Tomasetti, Lu Li, Simeon Springer, Isaac Kinde, Rachel Wong, Suzanne Kosmider, Ben Tran, Jayesh Desai, Theresa M. Hayes, Andrew Mark Haydon, Desmond Yip, Michael Christie, Robert Strausberg, Luis A. Diaz, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Peter Gibbs
Institutions: Walter and Eliza Hall Institute of Medical Research, Johns Hopkins University, Johns Hopkins Medicine, Eastern Health, Monash University, Western Health, The Royal Melbourne Hospital, St John of God Hospital, St John of God Health Care, The Alfred Hospital, Canberra Hospital, Ludwig Cancer Research
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2637669732